Discovery of 2,3-dihydro-1H-pyrrolo[3,4-b]quinolin-1-one derivatives as possible antileishmanial agents
Publication date
2022-06Author
Seth, A.Ghoshal, A.
Dewaker, V.
Rani, A.
Singh, S.P.
Dutta, M.
Katiyar, S.
Singh, S.K.
Rashid, M.
Wahajuddin, Muhammad
Kar, S.
Srivastava, A.K.
Peer-Reviewed
YesOpen Access status
closedAccessAccepted for publication
2022-05-22
Metadata
Show full item recordAbstract
A series of uniquely functionalized 2,3,-dihydro-1H-pyyrolo[3,4-b]quinolin-1-one derivatives were synthesized in one to two steps by utilizing a post-Ugi modification strategy and were evaluated for antileishmanial efficacy against visceral leishmaniasis (VL). Among the library compounds, compound 5m exhibited potential in vitro antileishmanial activity (CC50 = 65.11 μM, SI = 7.79, anti-amastigote IC50 = 8.36 μM). In vivo antileishmanial evaluation of 5m demonstrated 56.2% inhibition in liver and 61.1% inhibition in spleen parasite burden in infected Balb/c mice (12.5 mg kg-1, i.p.). In vitro pharmacokinetic study ascertained the stability of 5m in both simulated gastric fluid and simulated intestinal fluid. All the active compounds passed the PAINS filter and showed no toxicity in in silico predictions.Version
No full-text in the repositoryCitation
Seth A, Ghoshal A, Dewaker V et al (2022) Discovery of 2,3-dihydro-1H-pyrrolo[3,4-b]quinolin-1-one derivatives as possible antileishmanial agents. RSC Medicinal Chemistry. 13(6): 746-760.Link to Version of Record
https://doi.org/10.1039/D2MD00078DType
Articleae974a485f413a2113503eed53cd6c53
https://doi.org/10.1039/D2MD00078D